Larry R. Solomon

2.1k total citations
35 papers, 1.6k citations indexed

About

Larry R. Solomon is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Larry R. Solomon has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Larry R. Solomon's work include PARP inhibition in cancer therapy (5 papers), DNA Repair Mechanisms (3 papers) and Cell death mechanisms and regulation (3 papers). Larry R. Solomon is often cited by papers focused on PARP inhibition in cancer therapy (5 papers), DNA Repair Mechanisms (3 papers) and Cell death mechanisms and regulation (3 papers). Larry R. Solomon collaborates with scholars based in United States, Germany and United Kingdom. Larry R. Solomon's co-authors include Karl A. Walter, Peter A. Rubenstein, Philip J. Hajduk, John E. Harlan, Paul L. Richardson, Eric F. Johnson, Yan Shi, Edward T. Olejniczak, Thomas F. Holzman and David Maag and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Larry R. Solomon

34 papers receiving 1.6k citations

Peers

Larry R. Solomon

ONCOL

PHYSI

EPIDE

Kuo‐Sen Huang United States

Karen Lundgren United States

Ruth F. Nutt United States

Nachiket Vartak Germany

Yuko Murakami Japan

Sonya Zabludoff United States

Markus Boehm United States

Véronique Calleja United Kingdom

Bibek Gooptu United Kingdom

Marie Knockaert France

Kuo‐Sen Huang United States

Larry R. Solomon

2.0k ×2.0

359 ×0.8

ONCOL

238 ×0.8

PHYSI

284 ×1.4

EPIDE

384 ×2.1

Citations per year, relative to Larry R. Solomon Larry R. Solomon (= 1×) peers Kuo‐Sen Huang

Countries citing papers authored by Larry R. Solomon

Since Specialization

Citations

This map shows the geographic impact of Larry R. Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry R. Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry R. Solomon more than expected).

Fields of papers citing papers by Larry R. Solomon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry R. Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry R. Solomon. The network helps show where Larry R. Solomon may publish in the future.

Co-authorship network of co-authors of Larry R. Solomon

This figure shows the co-authorship network connecting the top 25 collaborators of Larry R. Solomon. A scholar is included among the top collaborators of Larry R. Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry R. Solomon. Larry R. Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Phillips, Darren C., Fritz G. Buchanan, Dong Cheng, et al.. (2021). Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors. Cancer Research. 81(12). 3402–3414. 32 indexed citations

Jin, Sha, Dan Cojocari, Julie J. Purkal, et al.. (2020). 5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis. Clinical Cancer Research. 26(13). 3371–3383. 126 indexed citations

Cojocari, Dan, Sha Jin, Julie J. Purkal, et al.. (2018). 5-Azacytidine Induces NOXA and PUMA Expression to Prime AML Cells for Venetoclax-Mediated Apoptosis. Blood. 132(Supplement 1). 2644–2644. 1 indexed citations

Tahir, Stephen K., Morey L. Smith, Larry R. Solomon, et al.. (2017). Abbv-621 Is a Novel and Potent TRAIL Receptor Agonist Fusion Protein That Induces Apoptosis Alone and in Combination with Navitoclax and Venetoclax in Hematological Tumors. Blood. 130. 2812–2812. 8 indexed citations

Hopkins, Todd A., Yan Shi, Luis E. Rodrı́guez, et al.. (2015). Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors. Molecular Cancer Research. 13(11). 1465–1477. 198 indexed citations

Shi, Yan, Larry R. Solomon, Vincent L. Giranda, et al.. (2011). Ubiquitin-specific Cysteine Protease 2a (USP2a) Regulates the Stability of Aurora-A. Journal of Biological Chemistry. 286(45). 38960–38968. 58 indexed citations

Liu, Xuesong, Yan Shi, David Maag, et al.. (2011). Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor. Clinical Cancer Research. 18(2). 510–523. 139 indexed citations

Yu, Liping, Rohinton Edalji, John E. Harlan, et al.. (2009). Structural Characterization of a Soluble Amyloid β-Peptide Oligomer. Biochemistry. 48(9). 1870–1877. 308 indexed citations

Korepanova, Alla, Larry R. Solomon, Karl A. Walter, et al.. (2008). Expression and purification of human TRPV1 in baculovirus-infected insect cells for structural studies. Protein Expression and Purification. 65(1). 38–50. 13 indexed citations

10.

Kage, Karen, Paul L. Richardson, Linda Traphagen, et al.. (2006). A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase. Journal of Neuroscience Methods. 161(1). 47–54. 21 indexed citations

11.

Longenecker, Kenton L., Philip J. Hajduk, Elizabeth H. Fry, et al.. (2005). Structure of MurF from Streptococcus pneumoniae co‐crystallized with a small molecule inhibitor exhibits interdomain closure. Protein Science. 14(12). 3039–3047. 56 indexed citations

12.

Joseph, Mary K., Larry R. Solomon, Andrew M. Petros, et al.. (2004). Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins. Oncogene. 23(3). 835–838. 4 indexed citations

13.

Snyder, Seth W., Rohinton Edalji, Frank Lindh, et al.. (1996). Initial characterization of autoprocessing and active-center mutants of CMV proteinase. Journal of Protein Chemistry. 15(8). 763–774. 5 indexed citations

14.

Mosley, James W., Cladd E. Stevens, F. Blaine Hollinger, et al.. (1995). Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion. 35(1). 5–12. 116 indexed citations

15.

Loike, John D., Roy L. Silverstein, Long Cao, et al.. (1993). Activated platelets form protected zones of adhesion on fibrinogen and fibronectin-coated surfaces.. The Journal of Cell Biology. 121(4). 945–955. 13 indexed citations

16.

Solomon, Larry R., et al.. (1992). Enzymatic syntheses of DNA-silicas using DNA polymerase. Analytical Biochemistry. 203(1). 58–69. 19 indexed citations

17.

Rubenstein, Peter A., et al.. (1989). Actin structure‐function relationships in vitro using oligodeoxynucleotide‐directed site‐specific mutagenesis. Cell Motility and the Cytoskeleton. 14(1). 35–39. 4 indexed citations

18.

Solomon, Larry R., et al.. (1988). Studies on the role of actin's aspartic acid 3 and aspartic acid 11 using oligodeoxynucleotide-directed site-specific mutagenesis.. Journal of Biological Chemistry. 263(36). 19662–19669. 27 indexed citations

19.

Solomon, Larry R.. (1986). Improvisation II. Perspectives of New Music. 24(2). 224–224. 9 indexed citations

20.

Solomon, Larry R. & Peter A. Rubenstein. (1985). Correct NH2-terminal processing of cardiac muscle alpha-isoactin (class II) in a nonmuscle mouse cell.. Journal of Biological Chemistry. 260(12). 7659–7664. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact